Related references
Note: Only part of the references are listed.Combining clinical and molecular data in regression prediction models: insights from a simulation study
Riccardo De Bin et al.
BRIEFINGS IN BIOINFORMATICS (2020)
Individual participant data meta-analysis to examine interactions between treatment effect and participant-level covariates: Statistical recommendations for conduct and planning
Richard D. Riley et al.
STATISTICS IN MEDICINE (2020)
A critical review of graphics for subgroup analyses in clinical trials
Nicolas M. Ballarini et al.
PHARMACEUTICAL STATISTICS (2020)
Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses
Stefan Schandelmaier et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
A review of spline function procedures in R
Aris Perperoglou et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
A systematic survey identified 36 criteria for assessing effect modification claims in randomized trials or meta-analyses
Stefan Schandelmaier et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)
Meta-analysis of non-linear exposure-outcome relationships using individual participant data: A comparison of two methods
Ian R. White et al.
STATISTICS IN MEDICINE (2019)
Meta-STEPP with random effects
Xin Victoria Wang et al.
RESEARCH SYNTHESIS METHODS (2018)
Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review
Emmanuelle Kempf et al.
BRITISH JOURNAL OF CANCER (2018)
Guidelines for the Content of Statistical Analysis Plans in Clinical Trials
Carrol Gamble et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?
David J. Fisher et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?
David J. Fisher et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
Peggy Sekula et al.
PLOS ONE (2017)
Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example
Klaus-Juergen Winzer et al.
PLOS ONE (2016)
Multivariable fractional polynomial interaction to investigate continuous effect modifiers in a meta-analysis on higher versus lower PEEP for patients with ARDS
Benjamin Kasenda et al.
BMJ OPEN (2016)
Which threshold for ER positivity? a retrospective study based on 9639 patients
M. Yi et al.
ANNALS OF ONCOLOGY (2014)
Interaction of treatment with a continuous variable: simulation study of power for several methods of analysis
Patrick Royston et al.
STATISTICS IN MEDICINE (2014)
Interaction of treatment with a continuous variable: simulation study of significance level for several methods of analysis
Patrick Royston et al.
STATISTICS IN MEDICINE (2013)
Prognosis research strategy (PROGRESS) 4: Stratified medicine research
Aroon D. Hingorani et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Analysing covariates with spike at zero: A modified FP procedure and conceptual issues
Heiko Becher et al.
BIOMETRICAL JOURNAL (2012)
Multivariate meta-analysis for non-linear and other multi-parameter associations
A. Gasparrini et al.
STATISTICS IN MEDICINE (2012)
Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
Douglas G. Altman et al.
PLOS MEDICINE (2012)
A critical review of methods for the assessment of patient-level interactions in individual participant data meta-analysis of randomized trials, and guidance for practitioners
D. J. Fisher et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
A new strategy for meta-analysis of continuous covariates in observational studies
Willi Sauerbrei et al.
STATISTICS IN MEDICINE (2011)
Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies
Simon Thompson et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Multivariable Model-building: A Pragmatic Approach to Regression Analysis Based on Fractional Polynomials for Modelling Continuous Variables by ROYSTON, P. and SAUERBREI, W.
David W. Hosmer
BIOMETRICS (2009)
A small sample study of the STEPP approach to assessing treatment-covariate interactions in survival data
Marco Bonetti et al.
STATISTICS IN MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Multivariate random-effects meta-analysis
Ian R. White
STATA JOURNAL (2009)
Two techniques for investigating interactions between treatment and continuous covariates in clinical trials
Patrick Royston et al.
STATA JOURNAL (2009)
Modelling to extract more information from clinical trials data: On some roles for the bootstrap
Willi Sauerbrei et al.
STATISTICS IN MEDICINE (2007)
Detecting an interaction between treatment and a continuous covariate: A comparison of two approaches
Willi Sauerbrei et al.
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2007)
Dichotomizing continuous predictors in multiple regression: a bad idea
P Royston et al.
STATISTICS IN MEDICINE (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials
P Royston et al.
STATISTICS IN MEDICINE (2004)
Patterns of treatment effects in subsets of patients in clinical trials
M Bonetti et al.
BIOSTATISTICS (2004)
Share Paper
